Organonitrogen Compounds
eMolecules 799283-92-4 | 1-(5-Bromopyrimidin-2-yl)piperidine-4-carboxylic acid | Oakwood Chemicals | MFCD03426070 | 286.129 | C10H12BrN3O2 | 0.000 | OC(=O)C1CCN(CC1)c1ncc(Br)cn1 | 1g | 480119073
1-(5-Bromopyrimidin-2-yl)piperidine-4-carboxylic acid | Oakwood Chemicals | 799283-92-4 | MFCD03426070 | 286.129 | C10H12BrN3O2 | 0.000 | OC(=O)C1CCN(CC1)c1ncc(Br)cn1 | 1g | 480119073
eMolecules 270912-79-3 | 2-((5-Bromopyrimidin-2-yl)oxy)acetic acid | Combi-Blocks | MFCD09753920 | 233.021 | C6H5BrN2O3 | 98.000 | OC(=O)COc1ncc(Br)cn1 | 1g | 415498882
2-((5-Bromopyrimidin-2-yl)oxy)acetic acid | Combi-Blocks | 270912-79-3 | MFCD09753920 | 233.021 | C6H5BrN2O3 | 98.000 | OC(=O)COc1ncc(Br)cn1 | 1g | 415498882
![eMolecules 128501-82-6 | 3-[(Diethylamino)methyl]-4-methoxybenzaldehyde | Combi-Blocks | MFCD01822193 | 221.300 | C13H19NO2 | 95.000 | CCN(CC)Cc1cc(C=O)ccc1OC | 5g | 482935747](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502185541.JPG-250.jpg)
eMolecules 128501-82-6 | 3-[(Diethylamino)methyl]-4-methoxybenzaldehyde | Combi-Blocks | MFCD01822193 | 221.300 | C13H19NO2 | 95.000 | CCN(CC)Cc1cc(C=O)ccc1OC | 5g | 482935747
3-[(Diethylamino)methyl]-4-methoxybenzaldehyde | Combi-Blocks | 128501-82-6 | MFCD01822193 | 221.300 | C13H19NO2 | 95.000 | CCN(CC)Cc1cc(C=O)ccc1OC | 5g | 482935747
eMolecules 1459771-55-1 | ChemScene | 1-(5-Bromopyrimidin-2-yl)ethan-1-ol | 100mg | 603128825 | CS-0169408 | MFCD28681070 | 203.039 | C6H7BrN2O
AstaTech | 44-BIS(BROMOMETHYL)BIPHENYL | 1g | 448278113 | T70531 | 95.000 | 20248-86-6 | MFCD00094419 | 340.058 | C14H12Br2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
eMolecules 514222-44-7 | 1,1'-(1,3-Phenylene)bis-1H-1,2,4-triazole | Toronto Research Chemicals | MFCD22666583 | 212.216 | C10H8N6 | 95.000 | c1ncn(n1)-c1cccc(c1)-n1cncn1 | 250mg | 483430666
1,1'-(1,3-Phenylene)bis-1H-1,2,4-triazole | Toronto Research Chemicals | 514222-44-7 | MFCD22666583 | 212.216 | C10H8N6 | 95.000 | c1ncn(n1)-c1cccc(c1)-n1cncn1 | 250mg | 483430666
eMolecules 771-14-2 | 2-Bromo-1-naphthylamine | Accela ChemBio | MFCD11870111 | 222.085 | C10H8BrN | 97.000 | Nc1c(Br)ccc2ccccc12 | 10g | 783626970
2-Bromo-1-naphthylamine | Accela ChemBio | 771-14-2 | MFCD11870111 | 222.085 | C10H8BrN | 97.000 | Nc1c(Br)ccc2ccccc12 | 10g | 783626970
eMolecules 2055841-00-2 | 2-(5-bromopyrimidin-2-yl)acetic acid;sodium salt | 1g
Ambeed | 4-(Morpholinomethyl)benzonitrile | 1g | 525028534 | A126658 | 37812-51-4 | MFCD00454271 | 202.257 | C12H14N2O
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC 1,6-Hexanediaminium, N1,N1,N1,N6,N6,N6-hexamethyl-, bromide (1:2) | 55-97-0 | 99.9% | 25 G
Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor antagonist (nAChR) with mixed competitive and noncompetitive activity. It possesses anti-hypertensive properties and has been shown to attenuate sympathetic activity and blood pressure in spontaneously hypertensive animal models.
- Non-selective ganglionic nicotinic-receptor antagonist (nAChR)
- Exhibits mixed competitive and noncompetitive activity
- Attenuates sympathetic activity and blood pressure
- Targets apoptosis, cardiovascular disease, and neurological disease
- Appears as a white to off-white solid
Medchemexpress LLC Hexamethonium Bromide | 55-97-0 | MFCD00011787 | 50 G
Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor antagonist (nAChR) that exhibits both competitive and noncompetitive activity. It possesses anti-hypertensive properties and has been shown to attenuate sympathetic activity and blood pressure in spontaneously hypertensive animal models.
- Non-selective ganglionic nicotinic-receptor antagonist (nAChR)
- Features both competitive and noncompetitive activity
- Exhibits anti-hypertensive activity
- Attenuates sympathetic activity and blood pressure in animal models
- Targeted towards nAChR and apoptosis
- Relevant for cardiovascular and neurological disease research
Medchemexpress LLC Hexamethonium Bromide | 55-97-0 | 99.91% | 5 G
Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor (nAChR) antagonist, exhibiting both competitive and noncompetitive activity. It possesses anti-hypertensive properties and has been shown to reduce sympathetic activity and blood pressure in animal models of spontaneous hypertension.
- Non-selective ganglionic nicotinic-receptor antagonist
- Demonstrates mixed competitive and noncompetitive activity
- Exhibits anti-hypertensive activity
- Attenuates sympathetic activity
- Reduces blood pressure in spontaneously hypertensive animal models
Medchemexpress LLC Hexamethonium bromide | 55-97-0 | MFCD00008323 | 99.9% | 1 G
Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor (nAChR) antagonist with mixed competitive and noncompetitive activity. It possesses anti-hypertensive activity and has been shown to attenuate sympathetic activity and blood pressure in spontaneously hypertensive animal models.
- Non-selective ganglionic nicotinic-receptor antagonist (nAChR)
- Mixed competitive and noncompetitive activity
- Anti-hypertensive activity
- Attenuates sympathetic activity and blood pressure in spontaneously hypertensive animal models
Medchemexpress LLC Hexamethonium Bromide | 55-97-0 | MFCD00011787 | 99.9% | 10 G
Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor antagonist (nAChR) with mixed competitive and noncompetitive activity. It also exhibits anti-hypertensive activity and can attenuate sympathetic activity and blood pressure in spontaneously hypertensive animal models.
- Target: nAChR (nicotinic-receptor)
- Research areas: Apoptosis, cardiovascular disease, neurological disease
- Publications verification: 4 publications verification
Apexbio Technology LLC Hexamethonium Bromide 55-97-0 5g
Hexamethonium Bromide (CAS 55-97-0) is a bis-quaternary ammonium compound that acts as a selective antagonist of neuronal nicotinic acetylcholine receptors (nAChRs) located in autonomic ganglia By competitively inhibiting synaptic transmission at these receptors Hexamethonium Bromide effectively blocks ganglionic neurotransmission without significant effects on muscarinic receptors or neuromuscular junctions This property makes it a valuable tool in pharmacological studies investigating autonomic nervous system function and the physiological roles of ganglionic nAChRs in various experimental models